Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Hydrochloride, Tolperisone
2. Midocalm
3. Mydeton
4. Mydocalm
5. Tolperisone
1. 3644-61-9
2. Tolperisone Hcl
3. Midocalm
4. Muscalm
5. Tolperisone (hydrochloride)
6. 2,4'-dimethyl-3-piperidinopropiophenone Hydrochloride
7. 2-methyl-3-piperidino-1-p-tolylpropan-1-one Hydrochloride
8. Tolperisone Hydrochloride [jan]
9. 2-methyl-1-(4-methylphenyl)-3-(piperidin-1-yl)propan-1-one Hydrochloride
10. N-553
11. 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-1-propanone Hydrochloride
12. 3644-61-9 (hcl)
13. 8z075k2tig
14. 1-piperidino-2-methyl-3-(p-tolyl)-3-propanone Hydrochloride
15. Ncgc00094929-01
16. Dsstox_cid_25868
17. Dsstox_rid_81187
18. Dsstox_gsid_45868
19. Arantoick
20. Atmosgen
21. Besnoline
22. Isocalm
23. Kineorl
24. Metosomin
25. Abbsa
26. 2-methyl-3-(piperidin-1-yl)-1-p-tolylpropan-1-one Hydrochloride
27. 2-methyl-1-(4-methylphenyl)-3-piperidin-1-ylpropan-1-one;hydrochloride
28. Cas-3644-61-9
29. Tolperisonehydrochloride
30. Einecs 222-876-5
31. Av 650
32. Unii-8z075k2tig
33. 1-propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-, Hydrochloride
34. Muscalm (tn)
35. Mfcd00058211
36. Biocalm
37. Minacalm
38. Naismeritin
39. Tolfree
40. Tolisartine
41. Tolpidol
42. Ncgc00182078-02
43. Mls004773941
44. Schembl872770
45. Spectrum1501194
46. 2,4'-dimethyl-3-piperidino-propiophenone Hydrochloride
47. Chembl1395150
48. Dtxsid2045868
49. Chebi:32244
50. Propiophenone, 2,4'-dimethyl-3-piperidino-, Hydrochloride
51. Tolperisone Hydrochloride (jp17)
52. Hms1921p09
53. Pharmakon1600-01501194
54. Hy-b1139
55. Tox21_111360
56. Tox21_113139
57. Ccg-40311
58. Nsc757872
59. S4200
60. Tolperisone Hydrochloride [mi]
61. 2-methyl-1-(4-methylphenyl)-3-(1-piperidyl)propan-1-one Hydrochloride
62. Akos005167032
63. Tox21_111360_1
64. Ac-4685
65. Cs-4744
66. Ncgc00094929-02
67. Ncgc00178060-03
68. Tolperisone Hydrochloride [mart.]
69. As-12472
70. Bp-10588
71. Smr003500666
72. Tolperisone Hydrochloride [who-dd]
73. Ft-0603642
74. Ft-0675274
75. Sw219278-1
76. T1319
77. A18694
78. D01507
79. H12066
80. 644t619
81. Sr-01000872774
82. Tolperisone Hydrochloride, >=98% (hplc), Solid
83. Sr-01000872774-1
84. W-106614
85. Q27271220
86. F9995-4198
87. 2-methyl-3-(piperidin-1-yl)-1-(p-tolyl)propan-1-one Hydrochloride
88. 1-propanone, 2-methyl-1-(4-methylphenyl)-3-(1-piperidinyl)-, Hydrochloride (1:1)
| Molecular Weight | 281.82 g/mol |
|---|---|
| Molecular Formula | C16H24ClNO |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 281.1546421 g/mol |
| Monoisotopic Mass | 281.1546421 g/mol |
| Topological Polar Surface Area | 20.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 262 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Muscle Relaxants, Central
A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) (See all compounds classified as Muscle Relaxants, Central.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
77
PharmaCompass offers a list of Tolperisone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tolperisone manufacturer or Tolperisone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tolperisone manufacturer or Tolperisone supplier.
PharmaCompass also assists you with knowing the Tolperisone API Price utilized in the formulation of products. Tolperisone API Price is not always fixed or binding as the Tolperisone Price is obtained through a variety of data sources. The Tolperisone Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Abbsa manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Abbsa, including repackagers and relabelers. The FDA regulates Abbsa manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Abbsa API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Abbsa manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Abbsa supplier is an individual or a company that provides Abbsa active pharmaceutical ingredient (API) or Abbsa finished formulations upon request. The Abbsa suppliers may include Abbsa API manufacturers, exporters, distributors and traders.
click here to find a list of Abbsa suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Abbsa DMF (Drug Master File) is a document detailing the whole manufacturing process of Abbsa active pharmaceutical ingredient (API) in detail. Different forms of Abbsa DMFs exist exist since differing nations have different regulations, such as Abbsa USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Abbsa DMF submitted to regulatory agencies in the US is known as a USDMF. Abbsa USDMF includes data on Abbsa's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Abbsa USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Abbsa suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Abbsa Drug Master File in Japan (Abbsa JDMF) empowers Abbsa API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Abbsa JDMF during the approval evaluation for pharmaceutical products. At the time of Abbsa JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Abbsa suppliers with JDMF on PharmaCompass.
A Abbsa written confirmation (Abbsa WC) is an official document issued by a regulatory agency to a Abbsa manufacturer, verifying that the manufacturing facility of a Abbsa active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Abbsa APIs or Abbsa finished pharmaceutical products to another nation, regulatory agencies frequently require a Abbsa WC (written confirmation) as part of the regulatory process.
click here to find a list of Abbsa suppliers with Written Confirmation (WC) on PharmaCompass.
Abbsa Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Abbsa GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Abbsa GMP manufacturer or Abbsa GMP API supplier for your needs.
A Abbsa CoA (Certificate of Analysis) is a formal document that attests to Abbsa's compliance with Abbsa specifications and serves as a tool for batch-level quality control.
Abbsa CoA mostly includes findings from lab analyses of a specific batch. For each Abbsa CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Abbsa may be tested according to a variety of international standards, such as European Pharmacopoeia (Abbsa EP), Abbsa JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Abbsa USP).
